Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning-Reference-Cited by-同舟云学术

Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

Published:2017-03-21 Issue:14 Volume:123 Page:2661-2670
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Yucel Orhan Kemal¹,Saliba Rima M.¹,Rondon Gabriella¹,Ahmed Sairah¹,Alousi Amin¹,Bashir Qaiser¹,Ciurea Stefan O.¹,Popat Uday¹,Khouri Isa¹,Marin David¹,Rezvani Katy¹,Kebriaei Partow¹,Shpall Elizabeth J.¹,Champlin Richard E.¹,Oran Betül¹^ORCID

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30632/fullpdf

Reference41 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol.,1982

2. Myelodysplastic syndromes;Nimer;Blood.,2008

3. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome;Deeg;Blood.,2002